Laifukan COVID sun sake karuwa saboda Rashin Kayayyakin Bincike

A KYAUTA Kyauta 4 | eTurboNews | eTN
Written by Linda Hohnholz

Barkewar cutar ta kasance babban abin damuwa a duniya. Dangane da bayanan baya-bayan nan da Cibiyar Kimiyya da Injiniya ta Jami'ar Johns Hopkins ta buga, sama da mutane miliyan 5.6 ne suka mutu daga cutar a duk duniya, gami da Amurkawa sama da 872,000.

Dangane da kididdigar alurar riga kafi, bayanai daga CDC sun nuna cewa kusan kashi 63.5% na yawan jama'ar Amurka suna da cikakkiyar rigakafin cutar COVID-19. Koyaya, tun lokacin Godiya, an tabbatar da mutuwar kusan 84,000. Bambancin Omicron, yayin da yake ƙasa da kisa fiye da bambance-bambancen da suka gabata, har yanzu yana da saurin yaɗuwa kuma an kiyasta zai kai kashi 99.9% na duk sabbin lamuran a Amurka har zuwa watan Janairu. Na 22. Jiya, sama da sabbin maganganu miliyan 21 na mako-mako ne aka ba da rahoton a duk faɗin duniya, waɗanda aka fi yin rikodin tun farkon barkewar cutar, a cewar Hukumar Lafiya ta Duniya.

Sakamakon yawan sabbin kararraki, kayan gwaji sun yi karanci. A cewar Anthony S. Fauci, babban mai ba da shawara kan harkokin kiwon lafiya ga Shugaba Biden, zai kasance da matukar muhimmanci "muna samun karfin gwaji, musamman idan bukatar gwaji ta yi yawa, tare da hadewar Omicron bambance-bambancen kanta, da kuma lokacin hutu, inda mutane ke son samun wannan ƙarin tabbacin cewa an kare su, ko da an yi muku alluran rigakafi kuma an ƙarfafa ku.”

Todos Medical Ltd. tare da 3CL protease theranostic hadin gwiwa hadin gwiwa kamfani NLC Pharma Ltd., sanar jiya breaking labarai game da, "tabbatattun bayanai na wucin gadi na Tollovir ™ na baka antiviral 3CL protease inhibitor na asibiti gwaji na asibiti na asibiti (mai tsanani da tsanani). ) masu cutar COVID-2. Tollovir ya sadu da farkon ƙarshen ƙarshensa na rage lokaci zuwa haɓaka asibiti kamar yadda aka auna ta Tsarin Gargaɗi na Gaggawa na ƙasa 19 (NEWS2) kuma ya sadu da mahimman mahimman abubuwan ƙarshen asibiti na biyu, gami da cikakken raguwa a cikin mutuwar COVID-2. Kamfanin yanzu ya rufe gwajin asibiti na Mataki na 19 a hukumance saboda ingantattun bayanan ingancin wucin gadi. Jagorar gidan yanar gizon Shaare Zedek Cibiyar Kiwon Lafiya ta yanzu ta ba da izinin amfani da Tollovir™ a cikin marasa lafiya na COVID-2 na asibiti bisa tsarin amfani da tausayi.

Hakanan ana shirye-shiryen haɓaka Tollovir don lura da:

1) COVID-19 na yara a asibiti

2) Baligi mai matsakaici zuwa mai tsanani COVID-19 a cikin saitin marasa lafiya

3) matsakaita zuwa matsananciyar cutar COVID-19 na yara a cikin wurin marasa lafiya

4) maganin Dogon COVID a cikin manya

5) maganin Long COVID a cikin yanayin yara

ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:

  • Fauci, babban mai ba da shawara kan harkokin kiwon lafiya ga Shugaba Biden, zai kasance da matukar muhimmanci "muna samun karfin gwaji, musamman lokacin da bukatar gwaji ta yi yawa, tare da hadewar Omicron bambance-bambancen kanta, da kuma hutu. kakar, inda mutane ke son samun wannan ƙarin matakin tabbacin cewa an kare su, ko da an yi muku alurar riga kafi kuma an ƙarfafa ku.
  • Jiya, sama da sabbin maganganu miliyan 21 na mako-mako ne aka ba da rahoton a duk faɗin duniya, waɗanda aka fi yin rikodin tun farkon barkewar cutar, a cewar Hukumar Lafiya ta Duniya.
  • Tollovir ya sadu da farkon ƙarshen ƙarshensa na rage lokaci zuwa haɓakar asibiti kamar yadda aka auna ta Tsarin Gargaɗi na Gaggawa na ƙasa 2 (NEWS2) kuma ya sadu da mahimman mahimman abubuwan ƙarshen asibiti na biyu, gami da cikakken raguwa a cikin mutuwar COVID-19.

<

Game da marubucin

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...